GlassScriptPhysician profile
Beibei Oelrich
NPI 1144519018
$4,700.17
in general payments reported to CMS, 2019-2025
26 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,192 · 2020: $884 · 2021: $125 · 2022: $577 · 2023: $394 · 2024: $364 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,751.91 | 2019-2024 | Solyx Sis System, Ams 700 |
| Olympus Corporation of The Americas | $777.43 | 2020 | |
| Astellas Pharma US INC | $460.47 | 2019-2024 | Xtandi |
| Pfizer INC. | $273.81 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $183.89 | 2020-2024 | Xiaflex, Aveed |
| Olympus America INC. | $158.71 | 2019-2024 | Itind System |
| Medtronic, INC. | $157.01 | 2021-2025 | Interstim, Hawkone, Nuro |
| Allergan, INC. | $142.71 | 2019-2021 | |
| Endo USA, INC. | $119.01 | 2024-2025 | Xiaflex, Aveed |
| Medtronic USA, INC. | $111.76 | 2019-2020 | |
| Axonics, INC. | $92.07 | 2023-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $74.40 | 2019 | |
| Abbvie INC. | $70.80 | 2022-2023 | |
| Urovant Sciences INC | $38.58 | 2022 | |
| Teleflex LLC | $35.73 | 2023 | Urolift |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $29.76 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $29.68 | 2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $28.49 | 2022 | |
| Procept Biorobotics Corporation | $26.45 | 2025 | |
| Merck Sharp & Dohme LLC | $26.27 | 2023 | Dificid |
| Tolmar, INC. | $22.47 | 2025 | Jatenzo, Eligard |
| Progenics Pharmaceuticals, INC. | $19.80 | 2022 | |
| Ethicon US, LLC | $18.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $17.98 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beibei Oelrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.